hit counter
Aduro BioTech, Inc. (ADRO) Stock News Sentiment & Price - Sentifly
ADRO - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Aduro BioTech, Inc. (ADRO)

USA
Biotechnology
NASDAQ
ADRO Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
ADRO Latest news
Zacks Investment Research
Positive
Aduro Biotech (KDNY) Upgraded to Buy: What Does It Mean for the Stock?
2020-12-01 12:00

Aduro Biotech (KDNY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research
Positive
Aduro Biotech (KDNY) Reports Q3 Loss, Tops Revenue Estimates
2020-11-05 20:20

Aduro Biotech (KDNY) delivered earnings and revenue surprises of -291.30% and 37.71%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research
Negative
Aduro Biotech (KDNY) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
2020-10-29 12:35

Aduro Biotech (KDNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research
Positive
Aduro Biotech (KDNY) Upgraded to Buy: Here's What You Should Know
2020-10-16 12:00

Aduro Biotech (KDNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research
Positive
Here's Why Momentum Investors Will Love Aduro Biotech (KDNY)
2020-10-13 12:00

Does Aduro Biotech (KDNY) have what it takes to be a top stock pick for momentum investors? Let's find out.

GlobeNewsWire
Neutral
Chinook Therapeutics Closes Merger with Aduro Biotech and Completes $115 Million Private Placement Financing
2020-10-05 09:00

Combined Company Will H ave Over $275 Million in Operating Capital and Trade on Nasdaq under the Ticker Symbol “KDNY”

GlobeNewsWire
Neutral
Aduro Biotech Stockholders Approve Merger Agreement with Chinook Therapeutics
2020-10-01 16:05

One-for-Five Reverse Stock Split to be Effective October 2, 2020

GeekWire
Positive
Chinook Therapeutics raises $106M as it prepares to merge with Aduro Biotech
2020-08-19 10:32

Chinook Therapeutics, a biotech company creating targeted therapies for kidney diseases, raised an additional $106 million just before its planned merger with Aduro Biotech.

Zacks Investment Research
Neutral
Aduro Biotech (ADRO) Reports Q2 Loss, Tops Revenue Estimates
2020-08-03 19:15

Aduro Biotech (ADRO) delivered earnings and revenue surprises of -10.53% and 76.06%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research
Negative
Aduro Biotech (ADRO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
2020-07-30 12:33

Aduro Biotech (ADRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Loading more news...